WELCOME TO VISICORT
Improving the Success Rate of Corneal Transplants
Corneal disease is a leading cause of blindness worldwide and affects individuals of both genders and of all age groups.
- VISICORT is an EU-funded research project to help improve corneal transplant success.
- VISICORT has collected and analyzed more than 50,000 human bio-samples from 5 leading European eye hospitals and clinics.
- The VISICORT Foundation Biobank of bio-specimens will support future research in eye damage and disease.
- VISICORT has manufactured a mesenchymal stromal cell product that will be trialled in people under-going high-risk corneal transplantation at the Charité University Hospital in Berlin as part of a safety and feasibility study to mitigate rejection episodes.
https://visicort.eu/wp-content/uploads/2021/01/marten-bjork-6dW3xyQvcYE-unsplash-scaled.jpg
1707
2560
visicort_admin
http://visicort.eu/wp-content/uploads/2014/03/visicort_logo_final-300x126.jpg
visicort_admin2021-01-15 10:29:452021-01-15 10:42:32Trio of VISICORT PIs will present at 2021 CDx Biomarkers and Biobanking BioTec Pharma Summit
https://visicort.eu/wp-content/uploads/2020/12/david-travis-5bYxXawHOQg-unsplash-scaled-e1607603444207.jpg
1004
2528
visicort_admin
http://visicort.eu/wp-content/uploads/2014/03/visicort_logo_final-300x126.jpg
visicort_admin2020-12-10 12:31:202021-01-15 10:29:15VISICORT consortium meets on November 27, 2020
https://visicort.eu/wp-content/uploads/2020/12/victorien-ameline-EiXGlD3hmHQ-unsplash-1.jpg
355
1178
visicort_admin
http://visicort.eu/wp-content/uploads/2014/03/visicort_logo_final-300x126.jpg
visicort_admin2020-12-07 15:11:132020-12-08 10:49:15Corneal Transplant Follow-up Study II (CTFS II) – Does tissue matching reduce the risk of rejection in corneal transplants?Project Partners
News
Trio of VISICORT PIs will present at 2021 CDx Biomarkers and Biobanking BioTec Pharma SummitJanuary 15, 2021 - 10:29 am
VISICORT consortium meets on November 27, 2020December 10, 2020 - 12:31 pm
Corneal Transplant Follow-up Study II (CTFS II) – Does tissue matching reduce the risk of rejection in corneal transplants?December 7, 2020 - 3:11 pm
VISICORT receives a 6-month extensionNovember 6, 2020 - 5:06 pm
Exploitation news: A collaboration with Epimune GmbH beginsAugust 18, 2020 - 11:13 am
2020 COP&S conference coordinated by VISICORT PI Dr Bertrand Fabres slated for November 12 & 13thAugust 17, 2020 - 3:36 pm
VISICORT presented at Ophthalmology changing event, BerlinAugust 17, 2020 - 1:37 pm
Project Info
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.
